Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02441036 · ClinicalTrials.gov registry record · NA
Gene Expression Following Ultherapy® Treatment
A NA study, sponsored by Ulthera.
- Terminated
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT02441036 is a NA study that was terminated before completion, run by Ulthera. The registered enrollment target is 16 participants.
The verdict
NCT02441036, a NA study, was terminated before completion, sponsored by Ulthera.
- TERMINATED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
Up to 25 subjects will be enrolled and randomized. Randomized subjects will receive one single-side Ulthera® treatment in the pre-auricular region on the face. At each subject's scheduled facelift procedure, resected tissue will be obtained for analysis.
Interventions
- DEVICE Ultherapy Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2015-05-01 |
| Est. Completion | 2016-08-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02441036
The ClinicalTrials.gov registry entry for NCT02441036 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ulthera, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ultherapy Treatment is the first listed.
NCT02441036 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02441036 about?
NCT02441036 is a clinical study titled "Gene Expression Following Ultherapy® Treatment". Up to 25 subjects will be enrolled and randomized. Randomized subjects will receive one single-side Ulthera® treatment in the pre-auricular region on the face. At each subject's scheduled facelift procedure, resected tissue will be obtained for analysis.
What is the current status of trial NCT02441036?
This trial is currently terminated. It is a NA study. The enrollment target is 16 participants. The study started on 2015-05-01. Estimated completion is 2016-08-18.
What interventions are being tested in trial NCT02441036?
The interventions under investigation include: Ultherapy Treatment (DEVICE).
Who is sponsoring clinical trial NCT02441036?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.